Miller Howard Investments Inc. NY Invests $573,000 in Cardinal Health, Inc. (NYSE:CAH)

Miller Howard Investments Inc. NY acquired a new stake in shares of Cardinal Health, Inc. (NYSE:CAH) in the fourth quarter, HoldingsChannel reports. The fund acquired 4,847 shares of the company’s stock, valued at approximately $573,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of CAH. Entropy Technologies LP acquired a new position in Cardinal Health in the fourth quarter valued at approximately $1,596,000. Wilmington Savings Fund Society FSB lifted its holdings in shares of Cardinal Health by 2.8% in the 4th quarter. Wilmington Savings Fund Society FSB now owns 7,870 shares of the company’s stock worth $931,000 after purchasing an additional 211 shares during the last quarter. MWA Asset Management boosted its position in Cardinal Health by 2.9% during the 4th quarter. MWA Asset Management now owns 3,324 shares of the company’s stock valued at $393,000 after purchasing an additional 95 shares during the period. Global X Japan Co. Ltd. boosted its position in Cardinal Health by 6.3% during the 4th quarter. Global X Japan Co. Ltd. now owns 4,638 shares of the company’s stock valued at $549,000 after purchasing an additional 276 shares during the period. Finally, Livforsakringsbolaget Skandia Omsesidigt increased its position in Cardinal Health by 1,224.3% in the fourth quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 76,799 shares of the company’s stock worth $9,083,000 after buying an additional 71,000 shares during the period. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Trading Up 0.4 %

Shares of NYSE CAH opened at $127.62 on Monday. The firm has a 50-day moving average of $122.46 and a two-hundred day moving average of $115.41. The company has a market capitalization of $30.83 billion, a price-to-earnings ratio of 23.81, a PEG ratio of 1.49 and a beta of 0.63. Cardinal Health, Inc. has a twelve month low of $93.17 and a twelve month high of $132.84.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, topping analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. As a group, research analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be given a dividend of $0.5056 per share. This represents a $2.02 dividend on an annualized basis and a dividend yield of 1.58%. The ex-dividend date is Tuesday, April 1st. Cardinal Health’s dividend payout ratio (DPR) is presently 37.69%.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on CAH. Evercore ISI raised shares of Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price target for the company in a report on Tuesday, January 7th. Mizuho assumed coverage on shares of Cardinal Health in a research note on Wednesday, December 4th. They set an “outperform” rating and a $139.00 target price for the company. Morgan Stanley raised their price target on shares of Cardinal Health from $136.00 to $142.00 and gave the company an “overweight” rating in a research note on Friday, January 31st. Barclays boosted their price objective on Cardinal Health from $117.00 to $133.00 and gave the stock an “overweight” rating in a research report on Monday, November 4th. Finally, Jefferies Financial Group upgraded Cardinal Health from a “hold” rating to a “buy” rating and raised their target price for the company from $140.00 to $150.00 in a research report on Wednesday, February 5th. Four investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat, Cardinal Health has a consensus rating of “Moderate Buy” and an average price target of $136.87.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.